Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | USP2 | O75604 | 4/20 | 0.57 |
| ▸ | HKDC1 | Q2TB90 | 3/20 | 0.57 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.57 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.57 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.57 |
| ▸ | TNNI3 | P19429 | 2/20 | 0.57 |
| ▸ | TNNT2 | P45379 | 2/20 | 0.57 |
| ▸ | TNNC1 | P63316 | 2/20 | 0.57 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.57 |
| ▸ | MEN1 | O00255 | 2/20 | 0.57 |
| ▸ | MAPT | P10636 | 2/20 | 0.57 |
| ▸ | HPGD | P15428 | 2/20 | 0.57 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.57 |
| ▸ | NPC1 | O15118 | 1/20 | 0.57 |
| ▸ | RAB9A | P51151 | 1/20 | 0.57 |
| ▸ | LMNA | P02545 | 1/20 | 0.57 |
| ▸ | GLA | P06280 | 1/20 | 0.57 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.57 |
| ▸ | THRB | P10828 | 1/20 | 0.57 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL722959 | 1.00 | USP2 (0.57) | USP2HKDC1L3MBTL1TDP1HSD17B10 | |
| SCHEMBL5181436 | 1.00 | USP2 (0.57) | USP2HKDC1L3MBTL1TDP1HSD17B10 | |
| Ammonia Solution, Strong SCHEMBL5180048 | 0.99 | USP2 (0.56) | USP2HKDC1L3MBTL1TDP1HSD17B10 | |
| SCHEMBL3232003 | 0.96 | USP2 (0.60) | USP2HKDC1L3MBTL1TDP1HSD17B10 | |
| SCHEMBL13577086 | 0.96 | USP2 (0.60) | USP2HKDC1L3MBTL1TDP1HSD17B10 | |
| SCHEMBL13576873 | 0.96 | USP2 (0.60) | USP2HKDC1L3MBTL1TDP1HSD17B10 | |
| SCHEMBL5181812 | 0.96 | USP2 (0.60) | USP2HKDC1L3MBTL1TDP1HSD17B10 | |
| SCHEMBL5180928 | 0.88 | USP2 (0.58) | USP2HKDC1L3MBTL1TDP1HSD17B10 | |
| SCHEMBL1706253 | 0.87 | SLC28A3 (0.56) | USP2HKDC1L3MBTL1TDP1HSD17B10 | |
| SCHEMBL5181431 | 0.86 | USP2 (0.58) | USP2HKDC1L3MBTL1TDP1HSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7622563-B2 | Process for producing glycoside | MITSUI CHEMICALS, INC. (JP) | 2009-11-24 | — | — | US | disclosed |
| US-20050272921-A1 | Process for producing glycoside | MITSUI CHEMICALS, INC. (JP) | 2005-12-08 | — | — | US | disclosed |
| EP-1544207-A1 | PROCESS FOR PRODUCING GLYCOSIDE | Mitsui Chemicals, Inc. (JP) | 2005-06-22 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050272921-A1 | Process for producing glycoside | HAAO, OGA, MGAM | USP2 1058/4885HKDC1 472/4885L3MBTL1 4847/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.